Prime
Treatments
Testing and Advancements Index
The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.
FACT SHEET
Prime Treatments, Testing and Advancements Primer
PDF
Infectious Diseases: Prime Treatments, Testing and Advancements Overview
PDF
Prime Treatments, Testing and Advancements Index Methodology Guide
PDF
Prime Treatments, Testing and Advancements Factsheet
PDF
Prime Treatments, Testing and Advancements Index
VIDEO
INDEX KEY FACTS
Base Date: December 12, 2019
Total number of holdings:
67
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization
INDEX SYMBOLS
| Version | Bloomberg | Reuters | ISIN |
|---|---|---|---|
| Prime Treatments, Testing and Advancements Index GTR | PGERM | .PGERMG | DE000SL0A030 |
| Prime Treatments, Testing and Advancements Index NTR | N/A | .PGERMN | DE000SL0A022 |
| Prime Treatments, Testing and Advancements Index PR | N/A | .PGERMP | DE000SL0A014 |
INDEX COMPOSITION
| Component Name | Ticker | Weight |
|---|---|---|
| ZAI LAB LTD | ZLAB | 6.24% |
| LABORATORY CRP OF AMER HLDGS | LH | 6.17% |
| BIO-RAD LABORATORIES INC | BIO | 5.73% |
| QUEST DIAGNOSTICS INC | DGX | 5.48% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 4.92% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | 4.59% |
| BIONTECH SE | BNTX | 4.59% |
| EMERGENT BIOSOLUTIONS INC | EBS | 4.35% |
| VIR BIOTECHNOLOGY INC | VIR | 4.21% |
| MODERNA INC | MRNA | 4.20% |
| QUIDEL CORP | QDEL | 3.72% |
| ATEA PHARMACEUTICALS INC | AVIR | 3.49% |
| CUREVAC BV | CVAC | 3.47% |
| NOVAVAX INC | NVAX | 3.41% |
| I-MAB | IMAB | 2.78% |
| OPKO HEALTH INC | OPK | 2.27% |
| NANTKWEST INC | NK | 1.43% |
| DICERNA PHARMACEUTICALS INC | DRNA | 1.32% |
| TRANSLATE BIO INC | TBIO | 1.26% |
| INOVIO PHARMACEUTICALS INC | INO | 1.25% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 1.25% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 1.24% |
| VBI VACCINES INC | VBIV | 1.21% |
| LUMINEX CORP | LMNX | 1.01% |
| ALIGOS THERAPEUTICS INC | ALGS | 1.01% |
| VAXCYTE INC | PCVX | 0.96% |
| ELI LILLY & CO | LLY | 0.82% |
| ALEXION PHARMACEUTICALS INC | ALXN | 0.76% |
| MERIDIAN BIOSCIENCE INC | VIVO | 0.75% |
| ORASURE TECHNOLOGIES INC | OSUR | 0.73% |
| ENANTA PHARMACEUTICALS INC | ENTA | 0.72% |
| GILEAD SCIENCES INC | GILD | 0.66% |
| JOHNSON & JOHNSON | JNJ | 0.64% |
| REGENERON PHARMACEUTICALS | REGN | 0.64% |
| HOLOGIC INC | HOLX | 0.63% |
| ABBVIE INC | ABBV | 0.63% |
| BRISTOL-MYERS SQUIBB CO | BMY | 0.63% |
| ABBOTT LABORATORIES | ABT | 0.62% |
| GLAXOSMITHKLINE PLC-SPON ADR | GSK | 0.60% |
| VAXART INC | VXRT | 0.59% |
| MERCK & CO. INC. | MRK | 0.59% |
| ASTRAZENECA PLC-SPONS ADR | AZN | 0.58% |
| SANOFI-ADR | SNY | 0.58% |
| TAKEDA PHARM-ADR | TAK | 0.56% |
| PFIZER INC | PFE | 0.53% |
| SQZ BIOTECHNOLOGIES CO | SQZ | 0.46% |
| CHIMERIX INC | CMRX | 0.44% |
| OXFORD IMMUNOTEC GLOBAL PLC | OXFD | 0.43% |
| CEL-SCI CORP | CVM | 0.43% |
| DYNAVAX TECHNOLOGIES CORP | DVAX | 0.43% |
| SIGA TECHNOLOGIES INC | SIGA | 0.42% |
| CODIAK BIOSCIENCES INC | CDAK | 0.39% |
| XBIOTECH INC | XBIT | 0.36% |
| CUE BIOPHARMA INC | CUE | 0.33% |
| ATHERSYS INC | ATHX | 0.28% |
| ARBUTUS BIOPHARMA CORP | ABUS | 0.27% |
| CO-DIAGNOSTICS INC | CODX | 0.26% |
| HOOKIPA PHARMA INC | HOOK | 0.24% |
| PARATEK PHARMACEUTICALS INC | PRTK | 0.23% |
| CORMEDIX INC | CRMD | 0.22% |
| IBIO INC | IBIO | 0.20% |
| IMV INC | IMV | 0.19% |
| ASSEMBLY BIOSCIENCES INC | ASMB | 0.15% |
| ENOCHIAN BIOSCIENCES INC | ENOB | 0.12% |
| ENZO BIOCHEM INC | ENZ | 0.11% |
| CONTRAFECT CORP | CFRX | 0.11% |
| PHASEBIO PHARMACEUTICALS INC | PHAS | 0.09% |